Klaus‐Friedrich Bodmann

Prospective, Non-Interventional, Multi-Centre Trial of Tigecycline in the Treatment of Severely Ill Patients with Complicated Infections – New Insights into Clinical Results and Treatment Practice

Christian Eckmann, W. R. Heizmann, Eva Leitner et al. · Chemotherapy · 2011 · 32 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +16

Therapy of 1,025 Severely Ill Patients with Complicated Infections in a German Multicenter Study: Safety Profile and Efficacy of Tigecycline in Different Treatment Modalities

Klaus‐Friedrich Bodmann, W. R. Heizmann, Christof von Eiff et al. · Chemotherapy · 2012 · 31 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Tigecycline in the Treatment of Patients with Necrotizing Skin and Soft Tissue Infections Due to Multiresistant Bacteria

Christian Eckmann, W. R. Heizmann, Klaus‐Friedrich Bodmann et al. · Surgical Infections · 2015 · 22 citations

Pharmacy, Pharmacotherapy, Surgery +17

Potential savings through single-dose intravenous Dalbavancin in long-term MRSA infection treatment – a health economic analysis using German DRG data

Michael Wilke, Kerstin Worf, Birgit Preisendörfer et al. · PubMed · 2019 · 19 citations · Full text

Pharmacy, Pharmacoeconomics, Pharmacotherapy +15